Videos de Experimentos Relacionados
Un gran moretón en el cuerpo.
G Standen1, J Birchall, C Morse
1Department of Haematology, Bristol Royal Infirmary, UK. G.R.Standen@bristol.ac.uk
Lancet (London, England)
|June 17, 1999
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Precise half-life determination of <sup>131</sup>Ba and <sup>125</sup>Xe.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same author
Impaired memory in Sprague-Dawley rats exposed to complex groundwater mixtures of contaminants is associated with reduced cranial blood flow and hippocampal neurotoxicity.
Neurotoxicology·2024
Same author
Microsecond Isomer at the N=20 Island of Shape Inversion Observed at FRIB.
Physical review letters·2023
Same author
Crossing N=28 Toward the Neutron Drip Line: First Measurement of Half-Lives at FRIB.
Physical review letters·2022
Same author
Determination of the ^{27}Al Neutron Distribution Radius from a Parity-Violating Electron Scattering Measurement.
Physical review letters·2022
Same author
Precision Measurement of the Beam-Normal Single-Spin Asymmetry in Forward-Angle Elastic Electron-Proton Scattering.
Physical review letters·2020
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026